Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, September 26, 2018
Experic announced that Justin Lacombe, Ph.D. has joined its leadership team as Director of Pharmaceutical Development and Manufacturing Services.
read more
Thursday, December 07, 2023
Experic, a contract development and manufacturing organization (CDMO) and provider of clinical trial supply services, has unveiled the incorporation of a Harro Höfliger Modu-C CS Containment system at its New Jersey facility.
read more
Thursday, January 14, 2016
Experimental Pathology Laboratories, Inc. (EPL) has acquired Aclairo Pharmaceutical Development Group, Inc. (Aclairo).
read more
Expert System joins the fight against COVID-19 by granting biomedical researchers worldwide free access to its AI-based CRN tool effective immediately.
read more
Explora BioLabs, a national provider of preclinical vivarium space, vivarium management services, and contract research services, announced it has completed its acquisition of Novalex Biotech Resources, LLC, a vivarium service provider based here.
read more
Thursday, January 07, 2021
Explora BioLabs will launch its first East Coast facility here in mid-2021.
read more
Exploristics, has announced plans to launch an updated version of its cloud-based data analytics platform for clinical trial design, KerusCloud 2.0, by the end of the summer.
read more
Exscientia announced a strategic research collaboration, and license option agreement with Sanofi in metabolic disease.
read more
Exscientia has entered into a strategic drug discovery collaboration with GlaxoSmithKline.
read more
Exyte and Univercells Technologies are announcing a global partnership for optimized construction of modular standardized and flexible GMP manufacturing facilities for vaccines.
read more
EyeGate Pharmaceuticals has received an additional development milestone from a subsidiary of Valeant Pharmaceuticals International, Inc. under the Company’s License Agreement with Valeant, pursuant to which EyeGate has granted Valeant exclusive, ...
read more
Thursday, August 13, 2020
Eyenovia has entered into a license agreement for Arctic Vision to develop and commercialize MicroPine in Greater China and South Korea.
read more
Friday, December 06, 2019
EyePoint Pharmaceuticals announced the Company has entered into a formal two-year contract with one of the largest integrated delivery systems in the U.S. to offer DEXYCU within its network.
read more
Monday, November 04, 2019
EyePoint Pharmaceuticals has entered into a formal three-year contract with Vizient effective November 1, 2019, to offer DEXYCU®.
read more
EyePoint has entered into a purchase and marketing agreement with Vantage Outsourcing for Dexycu.
read more